Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Running Away from Part D: No Love for New Rx Benefit on Campaign Trail

This article was originally published in RPM Report

Executive Summary

It's no surprise that the Democratic Presidential candidates are attacking Medicare Part D. But the really bad news for Big Pharma is that the Republicans don't have anything nice to say about it either. At least for now.
Advertisement

Related Content

Medicare Rx in 2009: Re-Politicizing Drug Prices
Preparing for Health Care Reform: Why Big Pharma Thinks it Can Avoid Another "Hillarycare"
Medicare Rx at a Turning Point: Big Plans Stumble as Part D Enters a Pivotal Year
Free Speech--0710
Reimportation Revived? Or an Issue about to Expire?
Reimportation Revived? Or an Issue about to Expire?
The Part D Peak: Big Pharma's Blowout Quarter
The Part D Peak: Big Pharma's Blowout Quarter
Negotiating Price Negotiation: Why the Democrats Will Struggle to Pressure Part D Prices
Preparing for Year Two of Part D: CMS Puts a Premium on Stability

Topics

Advertisement
UsernamePublicRestriction

Register

PS080348

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel